Carlyle Group Inc. SYRE Holdings History
Carlyle Group Inc.'s Spyre Therapeutics Inc Holding Summary
As of 2025-03-31, Carlyle Group Inc. held - shares of Spyre Therapeutics Inc(SYRE), totaling N/A. This investment constitutes 0% of their stock portfolio, and Carlyle Group Inc. now holds 0% of the outstanding Spyre Therapeutics Inc(SYRE) stock.
The initial trade took place in 2023Q1. And since then Carlyle Group Inc. has made 2 purchases of SYRE, at an average price of $12.38, for a total of 19,240.00 shares. In addition, there have been 2 sales at an average price of $17.01 for 19,240.00 shares. Based on historical transaction data and SYRE's current price of $16.40, Carlyle Group Inc.'s estimated gain on his SYRE holdings is $89,273.60, reflecting a 37.49% gain to date.
Carlyle Group Inc. SYRE ($16.40) Holding Chart
Carlyle Group Inc. SYRE ($16.40) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
